Hospira free to relaunch Eloxatin copies; Femara outperforms tamoxifen in study;

> A court order that briefly blocked Hospira's approval to sell a generic version of the Sanofi-Aventis colon-cancer drug Eloxatin in the U.S. has been dissolved. Report

> New data in The New England Journal of Medicine suggest that use of Novartis' Femara for five years after breast cancer surgery works better than tamoxifen in postmenopausal women with early stage, hormone-receptor positive disease. Release

> Medicis Pharmaceutical settled a lawsuit that alleged Sandoz, the generics unit of Novartis, infringed on a patent supporting Medicis's acne drug Solodyn ER. Report

> Eli Lilly is on the hunt for an agency to take on the pan-European advertising account for its erectile dysfunction drug Cialis. Report

> British specialty pharma ProStrakan said first-half product sales rose by over a third, leaving it on track to meet its goal of breaking even this year. Report

> Gilead Sciences said EVP Gregg H. Alton has established a new stock trading plan to exercise and sell options each month through December 2010. Report

> The FDA tapped Dr. Lawrence R. Deyton, a VA health officer with extensive experience in soldiers' health issues, to lead its tobacco-regulation efforts. Report

Biotech News

> One of BIO's newest tactics aimed at educating the public about the organization and industry is an online site called district9facts.com, which hopes to capitalize on the success of the sci-fi box office hit with some news and views regarding biotech in the real world. And it's aimed at a whole new audience. Report

> Italy's Gentium saw its shares sag on the news that its experimental therapy to treat the blockage of small veins in the liver failed the primary and secondary endpoints of a late-stage trial. Report

> Faced with a disappointing set of late-stage data, Eli Lilly has stopped work on the osteoporosis drug arzoxifene--a program that had been counted as one of its top three near-term drug prospects. Report

Vaccine News

> Every winter, norovirus--more commonly called the vomiting virus--causes misery on board cruise ships and inside schools and other places where people often crowd together. Now a group of scientists say that they're preparing to start human tests on a new vaccine for the virus that was manufactured using tobacco plants. Report

> Australia inked orders for 21 million doses of swine flu vaccine from CSL as it set the stage for the world's first mass vax campaign to get underway in a matter of weeks. The first shipment of two million doses will go out next week with pregnant women, the chronically ill and health workers at the front of the line. Report

And Finally... Scientists are describing successful use of a test that enlists pinhead-sized worms in efforts to discover badly needed new antibiotics. Release